(2022). 阿伐曲泊帕转换治疗TPO受体激动剂难治性再生障碍性贫血疗效及安全性. Zhōnghuá xuèyèxué zázhì, 43(11), 921-927. https://doi.org/10.3760/cma.j.issn.0253-2727.2022.11.007
Chicago Style (17th ed.) Citation"阿伐曲泊帕转换治疗TPO受体激动剂难治性再生障碍性贫血疗效及安全性." Zhōnghuá Xuèyèxué Zázhì 43, no. 11 (2022): 921-927. https://doi.org/10.3760/cma.j.issn.0253-2727.2022.11.007.
MLA (9th ed.) Citation"阿伐曲泊帕转换治疗TPO受体激动剂难治性再生障碍性贫血疗效及安全性." Zhōnghuá Xuèyèxué Zázhì, vol. 43, no. 11, 2022, pp. 921-927, https://doi.org/10.3760/cma.j.issn.0253-2727.2022.11.007.
Warning: These citations may not always be 100% accurate.